|
|
Deficiency of pRb decreases hepatocyte sensitivity to TGF-β |
|
|
Abstract [ABSTRACT] Aim:to detect how Rb-deficiency will affect responses to TGF-β induced cell cycle arrest of hepatocyte. Methods: primary hepatocytes were isolated and cultured, and Rb-specific adenovirus siRNA was transformed into cells. Then TGF-β was added daily and cell growth and cell cycles variations. Western blot and FQ-RT-PCR were adopted to detect pRb, E2F, c-MYC and p16 expression changes. Results: Primary hepatocytes were isolated and infected withRb-specific siRNA adenovirus. In control cells, treatment with TGFβ prevented cells to enter S phase via decreased cMYC activity, activation of P16INK4A activity. In Rb-null hepatocytes, E2F and cMYC activity decreased slightly but P16INK4A was not activated and the great majority of cells continued cycling. Rb is therefore central to TGFβ-induced cell cycle arrest in hepatocytes. Conclusion: The present results show that otherwise genetically normal hepatocytes with disabled Rb genes respond less well to the antiproliferative effects of TGF-β.
|
Received: 29 December 2008
Published: 02 July 2009
|
|
|
[1] Gressner A M, Weiskirchen R.Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med,2006, 10:76~99
[2] Breitkopf K, Godoy P, Ciuclan L,et al.TGF-beta/Smad signaling in the injured liver. Z Gastroenterol,2006,44:57~66
[3] Renton K W, Deloria L B, Mannering G J.Effects of polyriboinosinic acid,polyribocytidylic acid and a mouse interferon preparation on cytochrome P-450-dependent mono-oxygenase systems in cultures of primary mouse hepatocytes.Molecular Pharmacology,1978, 14:672~681
[4] Oe S, Lemmer E R, Conner E A,et al.Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. Hepatology,2004, 40:1098~1105
[5] Bedossa P, Peltier E, Terris B,et al.Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology,1995, 21:760~766
[6] Paik S Y, Park Y N, Kim H, et al.Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules. Mod Pathol,2003, 16:86~96
[7] Park Y N, Chae K J, Oh B K,et al.Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta. Hepatogastroenterology,2004, 51:396~400
[8] Laiho M, DeCaprio J A, Ludlow J W,et al.Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell,1990,62:175~185
[9] 宋敬东,健伟,韩金祥,等. 人乳头瘤病毒疫苗的研究进展.中国生物工程杂志,2007,27(4):104~109
Song J D,Jang W,Han J X,et al.China Biotechnology,2007,27(4):104~109
[10] Choi B H, Choi M, Jeon H Y,et al.Hepatitis B viral X protein overcomes inhibition of E2F1 activity by pRb on the human Rb gene promoter. DNA Cell Biol,2001, 20:75~80
[11] Feng X H, Liang Y Y, Liang M,et al.Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B). Mol Cell,2002,9:133~143
[12] Seoane J, Pouponnot C, Staller P,et al.TGF-beta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol,2001, 3:400~408
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|